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Introduction: Several vaccines for respiratory syn-
cytial virus (RSV) are under development. Designing 
an effective vaccination programme for RSV requires 
information about the relative contribution of risk 
factors for severe RSV symptoms. Aim: To inform pre-
ventive strategies in Europe by quantifying the con-
tribution of key child, family and health service risk 
factors to the burden of RSV hospital admissions 
in young children. Methods: We constructed a birth 
cohort study of all singleton children born in Scotland 
between October 2009 and September 2012 using link-
age between birth registration, maternity, vaccination 
and hospital admission records, with follow-up until 
the age of 3 years. RSV-confirmed hospital admissions 
were defined using linkage to national laboratory sur-
veillance data. We estimated hospital admission rates 
per 1,000 child years and length of stay according to 
each risk factor. Cox proportional hazard regression 
models were used to estimate adjusted hazard ratios.
Results: There were 5,185 RSV admissions among the 
169,726 children in the cohort: 48.6% of admissions 
occurred before the age of 6 months, and 29.6% after 
the age of 1 year. Children born prematurely, small 
for gestational age, between July and December, with 
chronic conditions, older siblings, mothers < 30 years 
old or delayed infant vaccination had a significantly 
increased risk of admission. Minimising the risk posed 
by older siblings could reduce RSV admissions by up to 
34%. Conclusion: Future RSV vaccination programmes 
must protect children throughout early childhood. 
Vaccination and/or interventions to reduce transmis-
sion by older siblings could substantially reduce RSV 
hospital admissions.
Introduction
Respiratory syncytial virus (RSV) is a frequent cause 
of respiratory infection and the main cause of bron-
chiolitis [1], the most common reason for hospital 
admission in infants in the United Kingdom (UK) [2] 
and many other developed countries. RSV also leads 
to over 450,000 primary care consultations in children 
in the UK every year [3]. In childhood, symptoms of 
RSV infection are more severe at the youngest ages [4]. 
Further, RSV infection in young infants has been linked 
to wheezing and asthma in later childhood [5,6].
There is a lack of cost-effective preventive strategies 
for RSV infection. Palivizumab, a humanised monoclo-
nal RSV antibody, has been shown to reduce hospital 
admissions in children born preterm or with congenital 
heart disease [7], but is costly [8]. It is therefore only 
recommended in children at high risk of serious com-
plications, who have chronic heart or lung conditions 
or immunodeficiency [9]. However, over 80% of infants 
who are admitted to hospital with bronchiolitis in the 
UK are born at term and otherwise healthy [10].
RSV vaccination is likely to be the most effective preven-
tive strategy, and several vaccine candidates are under 
development [11]. Options include targeting pregnant 
women, infants or older children. Vaccine strategies 
need to account for the short period of immunity fol-
lowing natural infection [12] and the young age of chil-
dren with the most serious complications of RSV. Older 
siblings are an important source of infant infections in 
low-income country settings [13], however, there have 
been few studies of the contribution of older siblings to 
the burden of RSV hospital admissions in high-income 
countries [14]. The design of an effective RSV vaccina-
tion programme needs information on risk factors in 
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order to effectively prevent the maximum number of 
cases and severe complications. A systematic review 
identified few large-scale studies of multiple risk fac-
tors for confirmed RSV infection in economically devel-
oped countries [15]. Linkage of health administrative 
databases, including hospital admission data, offer 
a whole-population cohort design for investigating 
risk factors for RSV-related hospital admission [10,16-
18]. These studies have highlighted the importance 
of clinical risk factors for RSV-related admissions in 
infancy, such as prematurity and chronic heart and 
lung disease. However, estimation of risk related to 
family structure is difficult as such data are limited in 
electronic hospital databases and diagnostic coding is 
unreliable for specific infections such as RSV [19,20].
In this study we examine the relative contribution 
of child, family and healthcare risk factors for RSV-
associated hospital admission in the first 3 years of life 
to inform vaccination and other preventive strategies.
Figure 1
Flow chart of derivation of the final study cohort, respiratory syncytial virus hospital admissions birth cohort study, 
Scotland, 2009–2015 (n = 169,726)
Birth cohort: births between 
October 2009 and September 
2012
n = 175,387
6,158 RSV positive episodes 
linked to birth cohort
Child does not have emergency 
hospital record
n = 385
5,185 RSV confirmed 
admissions
5,384 positive RSV episodes 
linked to hospital emergency 
admission within 
linkage period
Hospital emergency admission 
not in 14 day linkage range
n = 389
Excluded n = 199
   Admissions at age > 3 years n = 186
   After end of follow-up period/
    Injury primary diagnosis n = 13
 98,969 emergency hospital 
admissions betweeen  1 Oct 2009 
and 31 Sep 2015 in birth cohort
Excluded n=5,661
   Mother not Scottish resident n = 356
   Birthweight < 500g n = 30
   Gestational age < 24 weeks n = 27
   Multiple birth n = 5,248
Birth cohort: 169,726 children
RSV: respiratory syncytial virus.
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Materials and methods
Data sources, study population and period
We developed a birth cohort study of all singleton 
children born in Scotland to Scottish resident moth-
ers between October 2009 and September 2012, using 
linkage between the following national administrative 
health databases: birth and death registration records, 
maternity records (the Scottish Morbidity Record; 
SMR-02), Scottish Birth Records (which records neo-
natal diagnoses), hospital admissions (SMR-01) and 
the infant vaccination registry (Scottish Immunisation 
Recall System, SIRS). RSV-confirmed admissions were 
identified via linkage to the Electronic Communication 
of Surveillance in Scotland (ECOSS) database, a public 
health surveillance database held by Health Protection 
Scotland (HPS), the national infection control agency. 
We excluded children with a birth weight less than 
500 g and children born at less than 24 weeks to ensure 
exclusion of stillbirths. Deterministic linkage between 
databases was carried out using the Community 
Health Index (CHI) number, a unique individual identi-
fier used across the Scottish National Health Service 
(NHS Scotland) from birth [21]. The completeness 
of CHI number in the datasets that were linked by 
the electronic Data Research and Innovation Service 
(eDRIS) for this study was very high, including 99.6% 
of records in birth registration data, 99.7% in Scottish 
Birth Records, and 99.8% in SMR-01 (Carole Morris, 
eDRIS, personal communication, June 2018). Linkage 
was carried out by eDRIS, and only de-identified data 
was made available to the research team.
Children were followed from birth until their third birth-
day, their date of death or the date of moving out of 
Scotland (as recorded on the national CHI database), 
whichever occurred first. Outcomes were measured in 
the period 1 October 2009 to 30 September 2015 to 
ensure all children were followed up for 3 years from 
birth (unless they died or emigrated before this).
Figure 2
Distribution of respiratory syncytial virus hospital admissions by month of age in children less than 3 years old, birth 
cohort study, Scotland, 2009–2015 (n = 5,185)
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Outcome
An RSV-confirmed hospital admission (hereafter 
referred to as RSV admission for brevity) was defined 
through linkage between SMR-01, the national hospi-
tal admission database, and ECOSS. ECOSS contains 
reports of positive test results reported by participat-
ing microbiology laboratories serving NHS hospitals 
in Scotland to HPS. Since a child could have multiple 
positive tests during the course of one illness, HPS 
link positive ECOSS reports of the same pathogen in 
the same patient into infection episodes based on the 
specimen collection dates. We defined an RSV admis-
sion as any non-injury-related emergency hospital 
admission with a linked positive RSV ECOSS episode 
with a specimen date up to 7 days before or after the 
hospital admission date. Injury-related hospital admis-
sions were defined as admissions where the primary 
diagnosis was an injury (International Classification 
of Diseases version 10 (ICD-10) codes S00-T79 [22]). If 
a child had more than one hospital admission within 
the 14-day window of an RSV-positive ECOSS episode, 
we selected the admission with the admission date 
nearest to the specimen collection date as the RSV-
associated admission.
Risk factors
Child-level risk factors
Gestational age was classified into a four-category 
variable using an established classification [23]: 
extreme, severe and moderate preterm (< 34 weeks), 
near-term (34–36 weeks), term (37–40 weeks) and 
post-term (≥ 41 weeks). Birth weight for gestational age 
categories were derived using birthweight centiles for 
Scottish children [24]. Small and large for gestational 
age was defined as having a birthweight less or greater 
than the 10th percentile for the particular gestational 
age, respectively. Children who were neither large nor 
small for gestational age were categorised as normal 
for gestational age. We used a previously developed 
list of ICD-10 codes to identify children with chronic 
conditions, including chronic heart, lung and neurologi-
cal conditions, who are at increased risk of RSV-related 
complications [25]. We searched for the relevant codes 
in Scottish Birth Records and during longitudinal hos-
pital records up to the age of 6 months. Annual quar-
ter of birth was coded into a four-category variable 
(January–March, April–June, July–September, October–
December). Apgar score at 5 minutes was coded as a 
binary variable (0–7 and ≥ 8). Prolonged postnatal stay 
after delivery was used as a further indicator of early-
life neurological or respiratory problems with potential 
long-term sequelae, and was coded into a binary vari-
able: ≤ 14 days or > 14 days.
Family-level risk factors
Number of siblings at birth was derived using the parity 
variable in SMR-02 maternity records, and coded into a 
three-category variable: no siblings, one sibling or two 
or more siblings. Maternal smoking during pregnancy 
was coded as a binary variable (yes/no). Socioeconomic 
status was measured using maternal age and area-
level deprivation. Maternal age was coded into a four-
category variable (< 20, 20–29, 30–39 and ≥ 40 years). 
The Scottish Index of Multiple Deprivation (SIMD) is an 
area-level indicator of deprivation derived from sev-
eral indicators (mainly from the UK Census) [26]. SIMD 
scores are calculated at small-area level, where each 
area includes 500 to 1,000 persons. SIMD scores were 
grouped into quintiles and linked to the child via the 
maternal postcode at delivery.
Health service-related risk factors
We examined vaccination delay as an indicator of 
access to preventive health services. Children in 
the birth cohort should have received three doses 
of pentavalent (diphtheria/tetanus/pertussis/polio/
Haemophilus influenzae type B) vaccine and two doses 
of pneumococcal conjugate vaccine by 4 months of 
age. To examine the association between vaccination 
history and risk of RSV admission we defined a binary 
variable indicating delayed infant vaccination if a child 
had not received all required doses by the age of 6 
months.
Statistical analyses
All statistical analyses were carried out using Stata 
version 13 (StataCorp LP, College Station, TX, USA). We 
determined the number of RSV admissions according to 
month of age in the first 3 years of life, and estimated 
RSV admission rates per 1,000 child years by year of 
age and each risk factor. We estimated the median and 
interquartile range (IQR) of the length of stay of the 
RSV admissions according to each risk factor, and the 
proportion of total bed days (that is, the total number 
of days in hospital) during RSV admissions by each 
of the risk factors. Kruskal-Wallis tests were used to 
compare length of stay distributions. To calculate bed 
days, children with a length of stay of 0 days were allo-
cated 0.5 bed days.
Only the first RSV admission for each child in was 
included in the statistical models, and children who 
were admitted were censored at their admission date. 
We used Cox proportional hazards regression models 
to estimate adjusted hazard ratios according to each 
individual risk factor, adjusted for all others. The pro-
portional hazards assumption was checked using 
cumulative hazards plots. We included all risk factors 
in the model a priori. A separate model was fitted to 
evaluate the effect of delayed infant vaccination (since 
we defined this variable at age 6 months), with follow-
up started at age 6 months, rather than at birth. Since 
there was a non-negligible proportion of missing data 
on key risk factors, we used multiple imputation with 
15 imputations to estimate model parameters. A Wald 
test p value < 0.05 was used to determine whether a 
particular model parameter was significantly associ-
ated with the outcome. Complete case analyses were 
carried out as sensitivity analyses. Population attribut-
able fractions were calculated for all risk factors which 
were significantly associated with the outcome using 
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Table 1a
Distribution of respiratory syncytial virus hospital admissions, and median and interquartile range of length of stay in 
hospital according to risk factor, birth cohort study, Scotland, 2009–2015 (n = 5,185 admissions)
Risk factor Number of RSV hospital admissions
% of RSV hospital 
admissions
Median length of 
stay (IQR) in days
Kruskal-wallis test with ties 
p-value for difference in 
median length of stay
Number of 
bed daysa
% of 
bed 
days
Gestational age
< 34 weeks 268 5.2 3 (1–6.5)
0.0001
1,640.5 10.7
34–36 weeks 335 6.5 3 (1–5) 1,470.5 9.6
37–40 weeks 3,431 66.2 2 (1–4) 9,306 60.6
≥ 41 weeks 932 18.0 2 (1–4) 2,212 14.4
Missing 219 4.2 2 (1–4) 734.5 4.8
Sex
Boys 2,876 55.5 2 (1–4)
0.0628
8,580.5 55.8
Girls 2,309 44.5 2 (1–4) 6,783 44.2
Chronic condition recorded before 6 months
No 4,611 88.9 2 (1–4)
0.0001
12,235 79.6
Yes 574 11.1 3 (1–6) 3,128.5 20.4
Postnatal stay in hospital
≤ 14 days 4,833 93.2 2 (1–4)
0.0001
13,553 88.2
> 14 days 215 4.2 4 (1–7) 1,458 9.5
Missing 137 2.6 2 (0–3) 352.5 2.3
Season of birth
January–March 990 19.1 2 (1–4)
0.0001
3,192 20.8
April–June 977 18.8 1 (0–3) 2,394 15.6
July–September 1,453 28.0 2 (1–3) 3,934 25.6
October–
December 1,765 34.0 2 (1–4) 5,843.5 38.0
Apgar score at 5 min
0–7 195 3.8 2 (1–5)
0.0002
995.5 6.5
8–10 4,766 91.9 2 (1–4) 13,596.5 88.5
Missing 224 4.3 2 (1–4) 771.5 5.0
Birthweight by gestational age
Small for 
gestational age 486 9.4 2 (1–4)
0.7877
1,665.5 10.8
Right for 
gestational age 3,957 76.3 2 (1–4) 11,501 74.9
Big for 
gestational age 484 9.3 2 (1–4) 1,377.5 9.0
Missing 258 5.0 2 (1–4) 819.5 5.3
Number of siblings (parity)
None 1,547 29.8 2 (0–3)
0.0001
4200 27.3
1 1,995 38.5 2 (1–4) 5,703.5 37.1
≥ 2 1,435 27.7 2 (1–4) 4,900 31.9
Missing 208 4.0 1 (0–3) 560 3.6
Maternal smoking during pregnancy
No 3,471 66.9 2 (1–4)
0.0021
9862 64.2
Yes 1,246 24.0 2 (1–4) 4,201.5 27.3
Missing 468 9.0 2 (0–3) 1,300 8.5
IQR: interquartile range; RSV: respiratory syncytial virus.
a To calculate bed days, children with a length of stay of 0 days were allocated 0.5 bed days.
The 5,185 admissions were in 169,726 children, with total of 15,363.5 bed days.
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the punafcc command in Stata [27], from the complete 
case models. For the population attributable fractions, 
we assumed that the observed associations between 
each risk factor and RSV admission risk were causal.
Ethical approval
The study was approved by the Public Benefit and 
Privacy Panel for Health and Social Care, reference 
number 1516–0405.
Results
The cohort included 169,726 children, who were fol-
lowed for an average of 2.95 years. The characteristics 
of children in the cohort are shown in Table S1, and the 
linkage outcomes in  Figure 1. There were 6,158 RSV-
positive ECOSS episodes linked to the birth cohort, of 
which 5,384 (87.4%) were linked to a hospital admis-
sion within 14 days of the sample date.
There were 5,185 RSV admissions in 5,033 children: 
4,884 children had one RSV admission (97.0%), and 
149 (3.0%) had two or more during the first 3 years 
of life. Of the 5,185 RSV admissions, 19.1% (n  =  989) 
occurred before the age of 2 months (Figure 2), and 
nearly half (48.5%) before 6 months (n = 2,517). A fur-
ther 29.6% (n  =  1,532) of RSV admissions during the 
first 3 years of life occurred after the age of 1 year.
Only 19.4% (n  =  965) of the 4,966 RSV admissions in 
children with a known gestational age were among chil-
dren who were either premature or with an underlying 
chronic condition. However, the median length of stay 
was significantly longer among premature babies and 
children with chronic conditions (Table 1). The overall 
median length of stay was 2 days but children born at 
less than 34 weeks or with chronic conditions had a 
median length of stay of 3 days. Children with known 
chronic conditions accounted for 11.1% of admissions 
but 20.4% of bed days.
The overall RSV admission rate in the first, second 
and third year of life was 21.9, 7.0 and 2.0 per 1,000 
child years respectively. Unadjusted RSV admission 
rates were higher throughout the first 3 years of life for 
children with chronic conditions, born at less than 34 
weeks of gestation, with a postnatal stay of more than 
14 days or a 5-minute Apgar score of less than 8 (Table 
S2). After the first year of life, RSV admission rates were 
similar by season of birth and size for gestational age.
In the fully adjusted model, premature birth, pres-
ence of chronic conditions, birth between July and 
December and being small for gestational age were the 
birth characteristics independently associated with an 
increased risk of RSV admission (Table 2). Being born 
post-term was associated with a decreased risk. Of the 
family characteristics, having one older sibling was 
Risk factor Number of RSV hospital admissions
% of RSV hospital 
admissions
Median length of 
stay (IQR) in days
Kruskal-wallis test with ties 
p-value for difference in 
median length of stay
Number of 
bed daysa
% of 
bed 
days
Maternal age
< 20 years 313 6.0 2 (1–4)
0.1589
981.5 6.4
20–29 years 2,478 47.8 2 (1–4) 6,995.5 45.5
30–39 years 2,076 40.0 2 (1–4) 6,280.5 40.9
≥ 40 years 150 2.9 2 (1–5) 631.5 4.1
Missing 168 3.2 2 (0–3.5) 474.5 3.1
SIMD quintile
1 Most deprived 1,485 28.6 2 (1–4)
0.3251
4,820.5 31.4
2 1,117 21.5 2 (1–4) 3,416 22.2
3 945 18.2 2 (1–4) 2,679.5 17.4
4 888 17.1 2 (1–4) 2,501 16.3
5 Least deprived 
or missingb 750 14.5 2 (1–5) 1,946.5 12.7
Incomplete infant vaccination at 6 monthsc
No 2,125 80.3 1 (0–3)
0.005
5,053.5 77.4
Yes or missingb 520 19.7 2 (0–4) 1,475 22.6
IQR: interquartile range; RSV: respiratory syncytial virus; SIMD: Scottish Index of Multiple Deprivation.
a To calculate bed days, children with a length of stay of 0 days were allocated 0.5 bed days.
b Fewer than five children had a missing value.
c Including RSV admissions occurring after 6 months of age only. Total number of admissions: 2,645. Total bed days: 6,528.5.
The 5,185 admissions were in 169,726 children, with total of 15,363.5 bed days.
Table 1b
Distribution of respiratory syncytial virus hospital admissions, and median and interquartile range of length of stay in 
hospital according to risk factor, birth cohort study, Scotland, 2009–2015 (n = 5,185 admissions)
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associated with an 80% increased risk of RSV admis-
sion (hazard ratio (HR) 1.80; 95% confidence interval 
(CI): 1.68–1.93), and having two or more older siblings 
was associated with double the risk of RSV admission 
compared with children without older siblings (HR 2.18; 
95% CI: 2.02–2.35). Further, maternal smoking during 
pregnancy and younger maternal age were associated 
with an increased risk of RSV admission.
Delayed infant vaccination was associated with an 
independent and statistically significant increased risk 
of RSV admission (adjusted HR 1.14, 95% CI: 1.03–1.25; 
see Table S3). The increased risk associated with pres-
ence of older siblings was substantially attenuated for 
children aged over 6 months (e.g. adjusted HR for pres-
ence of one sibling 1.44; 95% CI: 1.31–1.59; Table S3) 
Complete case analyses were very similar to models 
based on multiple imputation (Table S4).
Only 6.5% of RSV admissions would be prevented if the 
excess risk among children with chronic conditions was 
eliminated (Table 3). If all children had similar risks to 
post-term babies, 19% of RSV admissions could be 
prevented. However, removing the risk posed by older 
siblings or due to lower maternal age would reduce the 
number of RSV admissions by over 30%.
Discussion
Half of all RSV admissions in the first 35 months of life 
occur during the first 6 months, and 30% of admissions 
after age 1 year. Although children born with chronic 
conditions were at significantly increased risk of RSV 
admission throughout the first 3 years of life, only 19% 
of RSV admissions occurred in these high-risk chil-
dren. Children with older siblings were twice as likely 
to be admitted with RSV infection and we estimated 
that reducing this risk would reduce the number of RSV 
admissions by nearly one third. We also identified a 
14% increased risk of RSV admission among children 
who had a delay in completing the infant vaccination 
programme.
This is the most comprehensive study of RSV admis-
sions in the UK to date, and one of the few large-scale 
studies for RSV admission in the literature using labo-
ratory data to confirm RSV infection [14,25,28]. A key 
strength of this study was the use of a national birth 
cohort including all singleton births in Scotland over 
3 years with follow-up through linkage to administra-
tive health databases. This allowed us to quantify the 
contribution of each risk factor through calculation of 
population attributable fractions. Our approach also 
ensured minimal selection bias, loss to follow-up, and 
sufficient numbers to examine risks in small subgroups 
of children, including children born at less than 34 
weeks’ gestation. The well-established national data 
linkage infrastructure and universal recording of the 
CHI number on all healthcare interactions in Scotland 
enabled the examination of both clinical and family 
risk factors, and the association between vaccination 
history and risk of RSV admission. Rich administrative 
Table 2
Crude and adjusted hazard ratios for risk of respiratory 
syncytial virus hospital admission in children less than 
3 years old according to risk factor, birth cohort study, 
Scotland, 2009–2015 (n = 5,033 admissions)
Risk factor Crude HR (95%CI) Adjusteda HR (95% CI)
Gestational age
< 34 weeks 3.87 (3.42–4.38) 2.54 (2.10–3.06)
34–36 weeks 1.71 (1.53–1.92) 1.58 (1.41–1.77)
37–40 weeks 1 1
≥ 41 weeks 0.74 (0.69–0.80) 0.81 (0.75–0.87)
Sex
Boys 1 1
Girls 0.84 (0.79–0.89) 0.85 (0.81–0.90)
Chronic condition recorded before 6 monthsb
No 1 1
Yes 3.40 (3.11–3.72) 2.67 (2.42–2.94)
Postnatal stay in hospital
≤ 14 days 1 1
> 14 days 3.93 (3.41–4.53) 1.11 (0.90–1.37)
Season of birth
January–March 1 1
April–June 0.95 (0.87–1.04) 0.94 (0.86–1.03)
July–September 1.37 (1.26–1.49) 1.37 (1.26–1.49)
October–
December 1.74 (1.61–1.89) 1.77 (1.64–1.92)
Apgar score at 5 min
0–7 1.75 (1.51–2.02) 1.11 (0.95–1.29)
8–10 1 1
Birthweight by gestational age
Small for 
gestational age 1.25 (1.14–1.38) 1.14 (1.03–1.25)
Right for 
gestational age 1 1
Big for 
gestational age 0.95 (0.86–1.04) 1.02 (0.92–1.12)
Number of siblings (parity)
None 1 1
1 1.67 (1.57–1.79) 1.80 (1.68–1.93)
≥ 2 2.07 (1.92–2.22) 2.18 (2.02–2.35)
Maternal smoking during pregnancy
No 1 1
Yes 1.51 (1.42–1.62) 1.29 (1.20–1.39)
Maternal age
< 20 years 1.10 (0.98–1.24) 1.43 (1.26–1.63)
20–29 years 1.14 (1.08–1.21) 1.24 (1.16, 1.32)
30–39 years 1 1
≥ 40 years 0.88 (0.74–1.04) 0.77 (0.66–0.92)
SIMD quintile
1 Most deprived 1.18 (1.08–1.29) 0.91 (0.83–1.00)
2 1.09 (0.99–1.20) 0.91 (0.83–1.01)
3 1.02 (0.93–1.12) 0.92 (0.83–1.02)
4 1.03 (0.94–1.14) 0.98 (0.89–1.09)
5 Least deprived 1 1
CI: confidence interval; HR: hazard ratio; SIMD: Scottish Index of Multiple 
Deprivation.
a Adjusted for all other variables in model.
b Including congenital heart disease, congenital malformations of the 
respiratory system, neurological disease and chronic lung disease.
The 5,033 admissions were in 169,726 children.
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data resources such as this are required to measure 
the impact of a future RSV vaccination programme.
A limitation of using linked administrative health data-
bases is that testing for RSV in children presenting to 
hospital is likely to favour inclusion of children with 
more severe symptoms and those in high-risk groups. 
This is because there is no national swabbing and 
testing programme for children presenting to hospital 
with symptoms of respiratory infections in Scotland or 
elsewhere in the UK. Testing practices are likely to vary 
both according to hospital and child characteristics, as 
well as time of year. It is likely that younger children, 
those with more severe symptoms, children born pre-
maturely or with chronic illness are more likely to be 
tested. This may have underestimated the number of 
RSV admissions in older children. Likewise, length of 
stay would be longer for children who are tested for RSV 
if the likelihood of testing is related to increased illness 
severity; hence the estimates presented here may not 
be representative of all RSV admissions. If the prob-
ability of being swabbed and tested is higher among 
children with underlying health problems, this would 
lead to an overestimation of the hazard ratios and pop-
ulation attributable fractions for presence of chronic 
conditions and premature birth. A second limitation is 
that we could not define some risk factors explored in 
previous studies, such as early socialisation through 
group childcare [29], or mode of delivery [30]. Finally, 
we could not account for children who received pro-
phylactic treatment with palivizumab since there is no 
national individual-level hospital prescribing database 
in Scotland (or elsewhere in the UK).
Our findings have important implications for the design 
of a future RSV vaccination programme and for policies 
to prevent RSV admissions in the pre-vaccine era. As 
reported in other studies [17,25,28], we identified an 
increased risk of RSV admission among children born 
prematurely and with chronic conditions, and RSV 
admission rates in these children remained higher 
than among low-risk children across the first 3 years 
of life. Children in these high-risk groups accounted 
for a disproportionate number of bed days. Therefore, 
any future RSV vaccination programme needs to ensure 
that these children are protected until at least 3 years 
of age. Maternal vaccination is an attractive strategy 
since it would protect the youngest infants, however, 
it would require careful timing during pregnancy to 
ensure premature babies are protected.
We identified presence of older siblings as an impor-
tant risk factor for RSV admission. Older siblings are 
likely to spend substantial amounts of time in closed 
settings outside the home (nurseries and schools) 
where infection risk is high [31]. A household study 
in Kenya identified older siblings (the vast majority of 
whom were attending school) as the source of nearly 
three quarters of infant infections [13]. Children are 
also more likely than adults to spread infection to 
infants due to frequent hand-to-mouth contact, and 
lack of hygienic practices (such as frequent handwash-
ing and sneezing into tissues rather than hands).
Eliminating the risk posed by older siblings could 
reduce the number of RSV admissions by a third across 
the first 3 years of life. Vaccinating older siblings could 
therefore be an important strategy in the UK and other 
high-income countries in order to prevent RSV admis-
sions among the youngest children [14]. As Poletti et 
al. [32] demonstrate in a low-income country setting, 
there are different strategies through which protection 
from infection risk posed by older siblings could be 
incorporated into an RSV vaccination programme. For 
example, it could be achieved by a school-based vac-
cination programme. Such a programme would lead to 
a reduction in population-level transmission as well as 
directly protect young siblings of school-aged children 
from infection. Alternatively, sibling vaccination could 
complement a newly introduced routine infant vaccina-
tion programme for the first few years after introduc-
tion; however, the effect would wane with the number 
of years since introduction. Ultimately, the optimal 
design of an RSV vaccination programme which effec-
tively prevents infections and hospital admissions 
among infants and young children will depend on the 
availability, effectiveness, safety, likely uptake and 
cost of vaccines for different age groups. However, 
our results indicate that vaccination of older children 
should be considered as a potential scenario in future 
cost-effectiveness models for RSV vaccination pro-
grammes in a UK context. Further studies are required 
to determine the risk of RSV admission according to the 
age of older siblings.
Our results suggest other measures to reduce the 
spread from older siblings are also likely to reduce 
RSV admissions. A systematic review has identified 
Table 3
Population attributable fraction (as a percentage of 
admissions prevented) by risk factor and scenario, birth 
cohort study, Scotland, 2009–2015
Risk factor and scenario Population attributable fraction (95% CI)
Gestational age = post term 18.9 (13.8–23.7)
Season of birth = April–June 25.6 (21.0–30.0)
Chronic condition = No 6.5 (5.6–7.5)
Parity = 0 34.0 (31.0–36.9)
Maternal smoking during 
pregnancy = no 5.9 (4.2–7.7)
Maternal age = ≥ 40 years 31.4 (18.7–42.1)
Birth weight at gestational 
age = right for gestational age 1.6 (0.1–3.0)
Delayed infant vaccination = noa 2.5 (0.5–4.5)
CI: confidence interval.
a Children aged ≥ 6 months only.
Population attributable fraction of admissions prevented if the 
particular risk factor was set to that for the specified risk group 
for all children; all other variables are kept the same.
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evidence from several clinical trials that handwash-
ing is effective in reducing transmission of respira-
tory viruses from younger children in particular [33]. 
Interventions to limit transmission from siblings should 
focus on infants born between July and December, who 
had the highest risk of RSV admission in our study.
The risk of RSV admission in this study increased 
with decreasing maternal age. An increased risk of 
RSV admission with younger maternal age has also 
been reported in other studies [28,34]. This is likely 
explained by the strong association between young 
maternal age and low socioeconomic status. Further 
studies with more detailed data on living standards 
are required to explore which aspects of socioeco-
nomic status, such as poor housing quality [35,36], 
explain the observed increased risk of RSV admis-
sion in children with younger mothers. In addition, low 
socioeconomic status (as indicated by young maternal 
age) is associated with premature birth and intrauter-
ine growth restriction, which in themselves are risk 
factors for RSV admission, as we have demonstrated. 
Thus, the total contribution of young maternal age or 
maternal smoking to the risk of RSV admission may be 
underestimated in this study. Future work should also 
examine the causal pathways through which low socio-
economic status affects the risk of RSV admission.
We observed a small but significant increase in RSV 
admissions associated with delayed infant vaccina-
tion. Our study is the first to examine the role of timely 
infant vaccination and the risk of RSV admission in a 
high-income country setting [15]. None of the current 
infant vaccines are expected to provide direct protec-
tion from RSV infection (only secondary protection 
through prevention of bacterial co-infection). Delayed 
infant vaccination could indicate a lack of access to 
preventive health services. However, children whose 
infant vaccinations are delayed or incomplete are more 
likely to be from poor socioeconomic backgrounds 
or have long-term chronic illness [37-39], which may 
explain the association observed in this study.
Our study highlights that any future RSV vaccination 
programme will need to protect children throughout the 
early life course, and in particular children with chronic 
conditions, who remained at increased risk throughout 
the first 3 years of life. Further, protecting young chil-
dren from infection risk posed by older siblings, includ-
ing through vaccination of older children, could have a 
substantial impact on reducing RSV admissions.
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